Validation of reduced S-gene target performance and failure for rapid surveillance of SARS-CoV-2 variantsArticle Published on 2022-10-032022-11-16 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종, [키워드] acute infection AEGIS amplification anomalies B.1.1.529 cause changes in characteristic conducted Corporation COVID-19 COVID-19 test Critical diagnose diagnostic diagnostic PCR tests effective Ensuring Evolution of SARS-CoV-2 Lineage lineages molecular Mutation observation omicron Patient PCR PCR testing Pharmacy polymerase chain proportion public health reduced reverse transcription RT-PCR S-gene SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Science Sequencing Surveillance the United State Transmission validation variant variants Viral transmission virus Walgreen whole genome [DOI] 10.1371/journal.pone.0275150 PMC 바로가기
Cardiovascular Risks and Outcome in COVID-19 Positive Patients With Cardiovascular Disease Attending Primary Health Care Corporation in Qatar: A Retrospective Cohort StudyResearch article Published on 2022-10-012022-10-05 Journal: Mayo Clinic Proceedings: Innovations, Quality & Outcomes [Category] 치료기술, [키워드] age analyzed Attending B-type natriuretic peptide BNPB-type natriuretic peptide cardiovascular cardiovascular disease cohort study Comorbidity Complication coronavirus disease Corporation COVID-19 COVID-19 patient COVID-19 patients COVID-19Coronavirus disease CVD CVDCardiovascular disease diabete disease electronic medical record Factor greater hematologic higher risk Hospital admission Hospitalization hypertension inclusion criteria increase inpatient admission Kidney disease less liver disorder men morbidity and mortality Multivariate analysis neurologic obesity objective Other outcome Patient patients with COVID-19 patients’ data PHCCPrimary Health Care Corporation positive predict Primary Health Care Corporation problem reported Result risk SARS-CoV-2severe acute respiratory syndrome coronavirus 2 secondary care selected severe acute respiratory syndrome coronavirus 2 survived Symptom tested the median the patient [DOI] 10.1016/j.mayocpiqo.2022.08.001 [Article Type] Research article
Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trialArticle Published on 2022-09-302022-11-15 Journal: Medicine [Category] SARS, 진단, [키워드] 1:1 added Adding Analysis antagonists Anti-inflammatory anti-inflammatory agent approved cascade center Colchicine Corporation cytokine Cytokine storm Efficacy and safety Ethics evaluate hospitalized patient IL-6 IL-6 blockade include Inflammasome inhibiting institutional review board Invasive mechanical ventilation Local mechanism of action Mortality NLRP3 Open-label Patient peer-reviewed Primary outcome Randomized Randomized controlled trial receptor receptor protein reduce Result risk safety profile severe COVID-19 Severe COVID-19 pneumonia Study protocol submitted Tocilizumab upstream [DOI] 10.1097/MD.0000000000030843 PMC 바로가기
Interventions to respond to COVID 19 pandemic in Mumbai and way forwardArticle Published on 2022-04-012022-11-16 Journal: The Indian journal of tuberculosis [Category] 치료기술, [키워드] Active surveillance Advocacy communication and social marketing approach Clinical Management Protocol Cluster Collaborating Corporation COVID 19 declining Dharavi Establishing family fatality Follow-up incidence include Isolation management Ministry of Health Multi sectoral collaboration Mumbai pandemic public health reflect respond Task Force Taskforce. Testing tracing treating Welfare [DOI] 10.1016/j.ijtb.2021.04.013 PMC 바로가기
SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women임산부에서 확인된 감염 예방에 SARS-CoV-2 백신 효과Article Published on 2021-12-012022-09-11 Journal: The Journal of Clinical Investigation [Category] SARS, 변종, [키워드] 95% CI 95%CI adjusted Adjustment age Alpha variant Analysis Beta Beta variant Case-control Cohort cohort analysis Complication Control analysis Corporation COVID-19 Critical disease death disease distress during pregnancy Effectiveness Epidemiology first dose gestational age higher risk hospital Hospitalization Inclusion Infection Infectious disease Medicine mRNA vaccine mRNA vaccines National nationality Neonatal Pregnancy pregnant women Public respiratory distress SARS-COV-2 infection SARS-CoV-2 test SARS-CoV-2 vaccine SARS-CoV-2 vaccines second dose Support the vaccine vaccination Vaccine variant variants women [DOI] 10.1172/JCI153662 PMC 바로가기 [Article Type] Article
Behavioral Factors Associated with COVID-19 Risk: A Cross-Sectional Survey in JapanArticle Published on 2021-11-202022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, SARS, [키워드] avoidance Behavior behavioral change conducted contrary Corporation correlated COVID-19 COVID-19 pandemic cross-sectional diagnosed Diagnosis difference economic loss effective estimates exercise Factor identify individual Infection Intervention Japan less Multiple regression participant positively correlated Probability remote work Research SARS-CoV-2 SARS-COV-2 infection solution survey the SARS-CoV-2 with COVID-19 [DOI] 10.3390/ijerph182212184 PMC 바로가기 [Article Type] Article
Cancer Communication and User Engagement on Chinese Social Media: Content Analysis and Topic Modeling StudyOriginal Paper Published on 2021-11-102022-10-30 Journal: Journal of Medical Internet Research [Category] Coronavirus, MERS, SARS, [키워드] Cancer cancer treatment cancer-related information cancers Chinese communication conducted content Corporation Engagement Express generate greatest number Health help highest identify investigated media modeling objective platform provide public health regression analysis Result smoking social media Support Topic topic modeling user user engagement Weibo [DOI] 10.2196/26310 PMC 바로가기 [Article Type] Original Paper
The associations of previous influenza/upper respiratory infection with COVID-19 susceptibility/morbidity/mortality: a nationwide cohort study in South KoreaArticle Published on 2021-11-032022-10-04 Journal: Scientific Reports [Category] MERS, 바이오마커, [키워드] adjusted odds ratio analyzed association cohort study Corporation COVID-19 COVID-19 cohort COVID-19 pandemic COVID-19 patient COVID-19 susceptibility database death defined Diseases extracorporeal membrane oxygenation Influenza influenza infection insurance intensive care invasive ventilation Logistic regression Medical research morbidity Mortality Non-COVID-19 Participants respiratory infection Risk factors Signs and symptoms South Korea susceptibility treatment history was collected was related with COVID-19 [DOI] 10.1038/s41598-021-00428-x PMC 바로가기 [Article Type] Article
Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workersResearch Article Published on 2021-10-152022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] age Breakthrough infection Contact Control Corporation Course Cox regression analysis determine excluded exposure to Factor group HCW Healthcare system healthcare worker Infection Midwifery National negative test Patient positive Positive test predicted Presence professional Result risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RT-PCR SARS-CoV-2 testing Sex Symptom vaccination vaccine dose [DOI] 10.1371/journal.pone.0258820 PMC 바로가기 [Article Type] Research Article
The evaluation of factors affecting antibody response after administration of the BNT162b2 vaccine: a prospective study in JapanGlobal Health Published on 2021-10-132022-10-28 Journal: PeerJ [Category] COVID-19, [키워드] Administered administration Affect affecting age Analysis anti-SARS-CoV-2 antibody antibody production Antibody Response Antibody test Antibody titer Autoimmune disease blood sugar BMI BNT162b2 BNT162b2 vaccine calculated Cancer carried Corporation COVID-19 defined develop diabetes Effect evaluate Factor first vaccination groups hypertension Japan lack less likelihood Logistic regression analysis Lung disease mean value multivariate multivariate logistic regression no significant difference Older participant per day performed promoted proportion Prospective Study responses second vaccination significantly significantly higher single-center study Spike-specific antibody suppressor the median Tokyo vaccination Vaccination strategies Vaccine [DOI] 10.7717/peerj.12316 PMC 바로가기 [Article Type] Global Health